Landry Benjamin sold 29,478 shares of Health Catalyst, Inc. at $1.39 for −$41.0k on Nov 12, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
General Counsel
General Counsel
Filed Nov 13, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$40,950.84Shares × reported price
Shares traded
29,478Common Stock
Price per share
$1.39Reported price. Read footnotes for ranges.
% of reported position traded
10.48%This security and ownership context
Holdings after
251,894Direct
Trade date
Nov 12, 2026Sell
Filed
Nov 13, 2026, 4:42 PM ET1-day reporting delay
Accession
0001975281-26-000005Code S · Transaction 400890
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 281,372 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 11, 2026Sell70,000$1.43−$100,023Trade 400889
2 transaction rows in this filing. Joint filers share the same rows.

HCAT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HCAT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +21%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on August 12th, 2026 in accordance with Rule 10b5-1.